{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T20:05:59Z","timestamp":1766347559938,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,16]],"date-time":"2020-02-16T00:00:00Z","timestamp":1581811200000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.annder.2018.12.005","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T01:49:24Z","timestamp":1548812964000},"page":"143-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Porphyries cutan\u00e9es"],"prefix":"10.1016","volume":"146","author":[{"given":"J.-F.","family":"Cuny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.12.005_bib0240","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.annder.2018.12.005_bib0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/asheducation.V2012.1.19.3795678","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"2012","author":"Balwani","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.annder.2018.12.005_bib0250","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ijd.12305","article-title":"Cutaneous porphyrias. Part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology","volume":"52","author":"Horner","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijd.12016","article-title":"Cutaneous porphyrias part II: treatment strategies","volume":"53","author":"Tintle","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0260","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2018.12.005_bib0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.det.2014.03.001","article-title":"The cutaneous porphyrias","volume":"32","author":"Schulenburg-Brand","year":"2014","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2018.12.005_bib0270","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pro.405","article-title":"Structure and function of enzymes in heme biosynthesis","volume":"19","author":"Layer","year":"2010","journal-title":"Protein Sci"},{"key":"10.1016\/j.annder.2018.12.005_bib0275","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3324\/haematol.2013.091991","article-title":"Heme and erythropoiesis: more than a structural role","volume":"99","author":"Chiabrando","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.annder.2018.12.005_bib0280","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2018.12.005_bib0285","series-title":"Porphyria in Weedon's skin pathology","first-page":"495","author":"Weedon","year":"2010"},{"key":"10.1016\/j.annder.2018.12.005_bib0290","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejim.2014.03.011","article-title":"Gruppo Italiano Porfiria A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias","volume":"25","author":"Ventura","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.annder.2018.12.005_bib0295","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bpg.2010.08.010","article-title":"The acute hepatic porphyries: current status and future challenges","volume":"24","author":"Siegesmund","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.annder.2018.12.005_bib0300","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2796.2010.02335.x","article-title":"Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden","volume":"269","author":"Innala","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.annder.2018.12.005_bib0305","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","article-title":"Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors","volume":"32","author":"Andant","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-010-9231-2","article-title":"Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study","volume":"34","author":"Tollanes","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2018.12.005_bib0315","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jocn.2011.01.003","article-title":"The neurologic manifestations of the acute porphyrias","volume":"18","author":"Simon","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.annder.2018.12.005_bib0320","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2362.2012.02673.x","article-title":"Assessing nutritional status of acute intermittent porphyria patients","volume":"42","author":"Garc\u00eda-Diz","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.annder.2018.12.005_bib0325","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.annder.2018.12.005_bib0330","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1373\/clinchem.2008.117432","article-title":"Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies","volume":"55","author":"Aarsand","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.annder.2018.12.005_bib0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e3181d50928","article-title":"Familial and sporadic porphyria cutanea tarda. Clinical and biochemical features and risk factors in 152\u00a0patients","volume":"89","author":"Munoz-Santos","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2018.12.005_bib0340","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Caballes","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.annder.2018.12.005_bib0345","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0350","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annder.2018.12.005_bib0355","first-page":"489","article-title":"Porphyria cutanea tarda\u00a0in a child following multi-agent chemotherapy","volume":"13","author":"Lapresto","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0360","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.annder.2013.04.092","article-title":"L\u00e9sions scl\u00e9rodermiformes dans la porphyrie cutan\u00e9e tardive: six observations","volume":"140","author":"Khayat","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.12.005_bib0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mjd.2000.111338","article-title":"Pseudoporphyria","volume":"44","author":"Green","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0370","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/ced.12313","article-title":"Diclofenac-induced pseudoporphyria: an under-recognized condition?","volume":"39","author":"Turnbull","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0375","article-title":"Chlorophyll-induced pseudoporphyria with ongoing photosensitivity after cessation\u2013a case series of four patients","author":"Zhao","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.12.005_bib0380","article-title":"Sunitinib-induced pseudoporphyria","author":"Sanz-Motilva","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.12.005_bib0385","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1468-3083.2009.03456.x","article-title":"Skin fragility and blistering with imatinib mesylate","volume":"24","author":"Verma","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.12.005_bib0390","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0395","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archdermatol.2012.807","article-title":"Deferasirox for porphyria cutanea tarda","volume":"148","author":"Pandya","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ced.12202","article-title":"X-linked dominant protoporphyria: a new porphyria","volume":"39","author":"Seager","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.annder.2018.12.005_bib0410","first-page":"1009","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.annder.2018.12.005_bib0415","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archderm.1977.01640090077011","article-title":"Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases","volume":"113","author":"Mathews-Roth","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0420","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.12714","article-title":"Narrowband ultraviolet B phototherapy in erythropoietic protoporphyria: case series","volume":"170","author":"Sivaramakrishman","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0425","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc0805682","article-title":"An \u03b1-melanocyte\u2013stimulating hormone analogue in erythropoietic protoporphyria","volume":"360","author":"Harms","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.12.005_bib0430","article-title":"Long-term observational study of afamelatonide in 115\u00a0patients with erythropoietic protoporphyria","author":"Biocalti","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0435","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jca.21249","article-title":"Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature","volume":"27","author":"Pagano","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1016\/j.annder.2018.12.005_bib0440","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29\u00a0cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0445","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2011-03-342873","article-title":"ALAS2\u00a0acts as a modifier gene in patients with congenital erythropoietic porphyria","volume":"118","author":"To-Figueras","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2018.12.005_bib0450","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/jid.2011.5","article-title":"Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria","volume":"131","author":"Sarkany","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0455","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/B:BOLI.0000037341.21975.9d","article-title":"The third case of Doss porphyria (\u03b4-amino-levulinic acid dehydratase deficiency) in Germany","volume":"27","author":"Doss","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2018.12.005_bib0460","first-page":"499","article-title":"Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene","volume":"165","author":"To-Figueras","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.12.005_bib0465","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI111039","article-title":"Harderoporphyria: a variant hereditary coproporphyria","volume":"72","author":"Nordmann","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2018.12.005_bib0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10545-010-9237-9","article-title":"Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327","volume":"34","author":"Hasanoglu","year":"2011","journal-title":"J Inherit Metab Dis"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818313486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818313486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:07:15Z","timestamp":1758971235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818313486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0151963818313486"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.12.005","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porphyries cutan\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}